ANGELA M MYLES

Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecology LITTLE ROCK, AR NPI 1912092248

General Payments — all program years on this page

$4,616.81

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 190
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $399.83 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $399.8320

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Biogen, Inc. $154.478
Astellas Pharma US Inc $77.593
Sumitomo Pharma America, Inc. $36.472
Exeltis, USA Inc. $30.012
PFIZER INC. $25.151
SHIELD THERAPEUTICS INC $24.161
Organon LLC $18.731
Amgen Inc. $17.281
Hologic Sales and Service, LLC $15.971

By program year

Program yearAmountRecords
2018 $591.6926
2019 $548.9137
2020 $325.9122
2021 $446.7833
2022 $1,988.5341
2023 $315.1611
2024 $399.8320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1084878703 Hologic Sales and Service, LLC $15.97 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104813611 Biogen, Inc. $24.73 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104814701 Biogen, Inc. $19.11 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104819146 Biogen, Inc. $28.86 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104821360 Biogen, Inc. $23.56 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104831640 Biogen, Inc. $28.03 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104841732 Biogen, Inc. $1.68 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104845628 Biogen, Inc. $27.42 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104852942 Biogen, Inc. $1.08 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111658821 Amgen Inc. $17.28 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131646774 PFIZER INC. $25.15 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136309043 Organon Llc $18.73 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139308762 Astellas Pharma US Inc $23.30 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139357951 Astellas Pharma US Inc $29.81 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139416335 Astellas Pharma US Inc $24.48 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148894871 Sumitomo Pharma America, Inc. $21.32 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148894873 Sumitomo Pharma America, Inc. $15.15 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150000324 Exeltis, USA Inc. $13.26 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150000326 Exeltis, USA Inc. $16.75 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150158268 SHIELD THERAPEUTICS INC $24.16 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.